Despite the enormous progress made in unraveling the complexities of regulated gene transcription during the past few years (9, 21, 30) , novel regulatory factors are still being discovered. We are interested in factors that are involved in the organization of interaction between enhancers and promoters, a key process in transcription control. Previously, during the search for such factors, we identified mutations in three genes named enhancers of yellow [e(y)1, e(y)2, and e(y)3], as they influenced yellow expression in the bristles that was activated by a tissue-specific enhancer (15) . In combination with the zeste null allele, mutations in these genes strongly inhibited enhancer-dependent white expression (14) . The zeste protein recognizes DNA sequences located in the enhancer and promoter regions of certain genes (e.g., the white gene) and is able to mediate protein-protein interactions to generate multimeric zeste complexes (4, 29) . In spite of the fact that some mutations of zeste changing the specificity of zeste protein-protein interaction may strongly inhibit the target gene transcription depending on enhancer activity, the null allele of zeste induces only a weak effect on gene expression. The synergistic effects of the zeste null mutation and mutations in the e(y) genes on inhibition of enhancer-dependent white expression suggests that these genes share similar functions.
The e(y)1 gene was recently cloned and shown to encode Drosophila melanogaster (d) TAF II 40 protein (also called dTAF II 42) (37). TAF II s or TATA-binding protein-associated factors are components of TFIID, a basal RNA polymerase II transcription factor. TAF II s are highly conserved from yeast to mammals (for reviews, see references 39 and 40) and are considered to perform important functions in transcription initiation, core promoter recognition, and transcription activation as coactivators that mediate signals from enhancer-bound regulatory proteins (7, 9, 10, 18, 19, 23, 25, 42) . Both the human (h) and the yeast (y) homologues of dTAF II 40 (hTAF II 31 and yTAF II 17) are subunits not only of TFIID but also of the recently identified TBP-free TAF II -containing multiprotein complexes (including hTFTC, hPCAF, hSTAGA, and ySAGA [3, 6, 8] ).
The second isolated e(y) gene mutation, e(y)2 1 , has diverse weak effects on fly morphology: short stocky body, separated wings, eyes with altered facets, and low fertility (15) . It also influences the phenotype of weak mutations in the yellow, white, cut, and scute genes (13, 26) . Thus, the genetic data suggest that the e(y)2 protein influences the expression of many different genes.
Here we report the identification of the e(y)2 gene and demonstrate that it encodes a novel, ubiquitous, evolutionarily conserved chromatin-associated protein that does not contain any known structural domains. The e(y)2 protein is present in all tissues and at all stages of Drosophila development. It enhances transcription activation in an in vitro transcription system on chromatin but not on naked DNA templates. The e(y)2 protein coimmunoprecipitates with TAF II 40 and some other components of the Drosophila TFIID complex. Genetic data also demonstrate e(y)2-TAF II 40 interaction. Thus, genetic and biochemical data together suggest that e(y)2 participates in transcription regulation.
MATERIALS AND METHODS
Genetic crosses. Cultivation of flies, the mutations and constructs used in this work were described elsewhere (14, 24, 37 1 /Y preblastoderm embryos as described previously (31, 38) . Chromosomal insertions of P{w ϩ , e(y)2 ϩ } were tested by the reversion of the "w" phenotype, and the number of inserted copies was determined by Southern blot analysis using P element sequence as a probe.
Construction of libraries. Construction of cDNA and genomic libraries, RNA isolation, and Northern blot analysis were performed as described previously (37) .
Preparation of extracts. Nuclear extracts from Drosophila embryos (TRAX), which efficiently worked in in vitro transcription reactions, were used for the immunoprecipitation experiments. Extracts were obtained as described previously (34) by the lysis of nuclei from 0-to 6-h embryos with 0.4 M ammonium sulfate. The final extract contained 15 to 20 mg of protein per ml in HEMG 100 buffer (25 mM HEPES, pH 7.6; 100 mM KCl; 12.5 mM MgCl 2 ; 0.1 mM EDTA, pH 8.0; 1 mM dithiothreitol [DTT]; 0.2 mM phenylmethylsulfonyl fluoride [PMSF]; 10% glycerol). Cytoplasmic extracts used for chromatin assembly were obtained as described previously (2, 5) . Dechorionated, 0-to 90-min embryos of Drosophila were washed with EW (0.7% NaCl; 0.05% Triton X-100), 0.7% NaCl, and EX-10 buffer (10 mM HEPES-KOH, pH 7.6; 10 mM KCl; 6.5 mM MgCl 2 ; 0.5 mM EGTA; 10% glycerol; 1 mM DTT; 0.2 mM PMSF) and then homogenized in Potter-Elvehjem homogenizer in EX-10 buffer. Turbid cytoplasmic extracts obtained after centrifugation for 5 min at 17,000 ϫ g were further centrifuged for 2 h at 190,000 ϫ g. Cytoplasmic extracts from Drosophila cell culture (Schneider) were obtained by lysis of cells washed in buffer (15 mM potassium phosphate, pH 7.0; 80 mM KCl; 16 mM NaCl; 5 mM MgCl 2 ; 1% PEG 6000). Cells were homogenized in small glass-Teflon homogenizer, and nuclei were pelleted by centrifugation for 5 min at 17,000 ϫ g.
Immunoprecipitation Superose-6 chromatography, Western blot analysis, and immunodetection experiments. The recombinant His-tagged e(y)2 protein was expressed using the pQE-30 expression vector (Qiagen). To generate e(y)2 antibodies, the affinity-purified His-tagged e(y)2 protein was injected into rabbits. Rabbit polyclonal antibodies raised against His-tagged e(y)2 protein were affinity purified and used in Western blot analysis, immunodetection, and immunoprecipitation experiments.
In immunoprecipitation experiments, 150 g of nuclear extract in 400 to 500 l of immunoprecipitation buffer (IP buffer; 25 mM Tris-HCl, pH 7.9; 10% [vol/vol] glycerol; 0.1% NP-40; 0.5 mM DTT; 5 mM MgCl 2 ) containing 100 mM KCl was immunoprecipitated with 40 l of protein A-Sepharose (Pharmacia) and approximately 2 g of antibody. Antibody-protein A-Sepharose-bound complexes were washed three times with IP buffer containing 0.5 M KCl and two times with IP buffer containing 0.1 M KCl. In the experiment shown in Fig. 4D , antibody-protein A-Sepharose-bound complexes were washed with IP buffer containing 1 M KCl. After being washed 10 l of beads was boiled in sample buffer, and proteins were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). For chromatography, 200 l of nuclear extract (TRAX) was loaded on a Superose-6 10/30 column and equilibrated with buffer (20 mM HEPES-KOH, pH 7.6; 400 mM KCl; 1 mM MgCl 2 ; 0.5 mM EGTA; 1 mM DTT; 20% glycerol) at a flow rate of 0.1 ml/min. Fractions of 0.5 ml were collected. The antibodies used were described previously (17) . Immunostaining of polytene chromosomes and tissue sections was performed as described previously (37) .
Chromatin assembly and incubation in transcription extract. A 7.75-kb plasmid containing hsp26 minigene (33) was used as a template. The chromatin reconstitution on DNA templates immobilized on Dynabeads M280 (Dynal) and the monitoring of chromatin assembly were performed as described earlier (5, 27, 32, 34) . Naked or chromatin DNA templates (1.5 g) immobilized on beads were incubated in a scaled-up transcription reaction (34) containing 30 l of transcription extract (TRAX) per 200 l of total volume in the presence of 2.5 mM ATP for 30 min at 26°C. Beads were washed three times with 400 l of HEMG 100 and resuspended in SDS gel loading buffer.
In vitro transcription experiments. The in vitro transcription system was as previously described (11, 12) . Chromatin was assembled using Drosophila embryonic extract (28) on supercoiled circular DNA and tested by micrococcal nuclease digestion as described earlier (2, 12) . His-tagged e(y)2 and/or GAL4-VP16 were added to the template and incubated for 30 min at 27°C prior to transcription initiation. Transcription was quantitated by S1 nuclease analysis (35, 41) by using the 32 P-labeled probe that hybridized with the transcripts from the (17M)5␤2G and pG1 sites to yield fragments of 179 and 60 nucleotides, respectively. Transcription was quantitated using a PhosphorImager.
Search for e(y)2 homologues and analysis of amino acid sequences. Searches were performed using the BLAST (National Center for Biotechnology Information) computer program (1) . UniGene clusters Hs.56002, Rn.3365, and Mm.10219 correspond to human, rat, and mouse expressed sequence tags (EST). The final nucleotide sequences of human, rat, and mouse cDNAs were obtained as a result of alignment of all EST sequences. To confirm the sequences, we cloned and sequenced e(y)2 cDNA using reverse transcription-PCR. The multiple sequence alignment of proteins was done with the PIMA 1.4 program (36); the pairwise sequence alignment was done with the BLAST 2 program (1). Sequences obtained in this work were submitted to GenBank under the following accession numbers: genomic DNA in region of localization of Drosophila e(y)2 gene (AF173294); cDNA of the e(y)2 gene from D. melanogaster (AF173295), mouse (AF173297), and human (AF173296).
RESULTS

Cloning of the e(y)2 gene and structure of the e(y)2 gene and protein. The e(y)2
1 mutation was shown to be induced by insertion of the Stalker mobile element (16) into a site localized to the 10C2-C4 region of the X chromosome according to deletion mapping and in situ hybridization with a Stalker probe. The e(y)2 gene was cloned by chromosomal walk from the gene encoding the largest subunit of RNA polymerase II located in the same region (20, 43) . Clones containing sequences homologous to Stalker were found on the first step of the walk. The adjacent genomic sequence was used as a probe for the isolation of wild-type clone from the Oregon R strain. Three transcripts were mapped close to the place of Stalker insertion (Fig. 1A) . However, only the smallest of them (0.5 kb) was under-represented in the mutant e(y)2 1 strain compared to the wild-type one (Fig. 1B) .
To prove that the 0.5-kb transcript corresponds to the e(y)2 gene, the wild-type genomic region encoding this transcript (see Fig. 1C , e(y)2 ϩ } lines. Thus, the 0.5-kb transcript does indeed correspond to the e(y)2 gene. Sequencing of the obtained genomic and cDNA clones showed the absence of introns in the e(y)2 gene. The deduced amino acid sequence revealed a small protein, 101 amino acids long, without any homology to known proteins.
The e(y)2 1 mutation is caused by the insertion of the Stalker mobile element 167 bp upstream of the 5Ј end of the largest cDNA clone. The size and structure of the e(y)2 transcript were not changed by this mutation. The only molecular effect of Stalker insertion was a reduced level of e(y)2 transcription (ca. three-to fourfold decrease of the mRNA content in adult males). Thus, e(y)2 1 represents a weak hypomorph mutation.
Presence of the homologous genes in other species.
No homologues of the e(y)2 gene were detected by BLAST search among already-known genes. On the other hand, a search in EST data bank has revealed cDNA's encoding homologous proteins in a wide range of species from mammals and protozoa to plants ( Fig. 2A) . The e(y)2 homologues were found among EST clones obtained from different human (including bone, brain, heart, and kidney) and mouse (including unfertilized egg, embryo, kidney, liver, and muscle) tissues. The 5Ј upstream region of human homologue is CpG-rich (80 CpG for 1 kbp of promoter region), a characteristic feature of housekeeping genes (Fig. 2C) .
All homologous proteins are of similar size, and the region of homology is spread over the entire length of different e(y)2 proteins ( Fig. 2A) . The amino acid sequences of human, rabbit, rat, and mouse proteins are identical. Human and Drosophila proteins contain 48% identical and 27% similar amino acids. Still the human protein is recognized by polyclonal antibodies directed against recombinant Drosophila e(y)2 (Fig.  2B) .
The e(y)2 protein has a nuclear localization and is present in all tissues of D. melanogaster. The e(y)2 gene is actively transcribed at all stages of development of D. melanogaster (Fig. 3A) . The e(y)2 protein is present in the nuclei of all tissues of adult flies (Fig. 3B ) and was detected in the nuclei from the earliest stages of embryonic development (data not shown). Separation of Drosophila Schneider cell homogenate into nuclear and cytoplasmic fractions also demonstrated e(y)2 protein to be limited to the nuclear fraction (Fig. 3D) Biochemical experiments to examine the interaction between e(y)2 and dTAF II 40. To further study the genetically identified interaction between e(y)2 and TAF II 40, we analyzed the proteins that coimmunoprecipitated together with either e(y)2 or different subunits of the distinct TAF II -containing complexes from Drosophila embryo nuclear extract. TFIID and other TAF II -containing complexes were immunoprecipitated using antibodies directed against either Drosophila TATAbinding protein (dTBP) or dTAF II 24, one of two recently discovered Drosophila homologues of human TAF II 30 (17) , while e(y)2-associated proteins were immunoprecipitated with a polyclonal sera raised against recombinant e(y)2. The proteins were then analyzed by Western blotting (Fig. 4A) .
In a good agreement with the genetic data, antibodies to e(y)2 coimmunoprecipitated dTAF II 40 and also other bona fide Drosophila TAF II s (such as dTAF II 230, dTAF II 110, and dTAF II 24) and TBP (Fig. 4A, Thus, the 13-kDa e(y)2 protein interacts with either TBP-or The immunoprecipitation with antibodies to e(y)2 depleted more than 90% of the e(y)2 protein from the input nuclear extract but reduced only slightly the amounts of TBP and of the different TAF II s (Fig.  4A ). Vice versa, the amount of e(y)2 coprecipitating with TBP and TAF II 24 did not seem to be stoichiometric, suggesting that only a minor fraction of e(y)2 may be associated with the TFIID complex.
To further study the association of e(y)2 with TAF II -containing multiprotein complexes, we carried out gel filtration experiments. Drosophila embryo nuclear extract was fractionated on a Superose-6 column. Western blot analysis of the Superose-6 fractions (Fig. 4B) revealed that e(y)2 eluted as a single peak and was present in fractions with apparent relative molecular masses of between 600 and 900 kDa, indicating that e(y)2 is a component of a large protein complex. dTAF II s and TBP eluted in fractions with apparent relative molecular masses of more than 800 kDa (Fig. 4B, fractions 16 to 24) . The single e(y)2 elution peak only slightly overlaps with TFIIDcontaining fractions (Fig. 4B, fractions 23 and 24) . Interestingly, the TAF II 40 elution peak is much larger (Fig. 4B , fractions 16 to 30) than that of the other tested dTAF II s and TBP, and thus the overlap is more prominent in the case of TAF II 40 and e(y)2.
To control the specificity of e(y)2 and TAF II 40 complex formation, we performed an immunoprecipitation with fraction 24 containing the maximal amount of e(y)2 and fraction 20 containing almost no e(y)2 (Fig. 4C) . The e(y)2 antibodies precipitated neither e(y)2 nor TAF II 40 from fraction 20 (Fig.  4C, lanes 4 and 5) , proving the absence of nonspecific precipitation. Antibodies raised against TAF II 40 precipitated almost all TAF II 40 and a very significant amount of e(y)2 in the fraction 24 (lane 11) and, vice versa, antibodies to e(y)2 precipitated almost all e(y)2 and about a half of the TAF II 40 in the fraction 24 (lane 10). Thus, e(y)2 and TAF II 40 are stably associated in fraction 24. In contrast, when the anti-e(y)2 immunoprecipitation from fraction 24 was tested for the presence of other TFIID components by Western blot, antibodies raised against TBP, TAF II 110 and TAF II 230 gave negative results (data not shown), suggesting that after gel filtration the other TAF II -containing complexes and the e(y)2-TAF II 40-containing complex are separated. Nevertheless, the e(y)2-TAF II 40 interaction seems to be relatively stable since TAF II 40 was still detected in anti-e(y)2 immunoprecipitations from the nuclear extract after the resin-bound proteins were washed in more stringent conditions (with IP buffer containing 1 M KCl) (Fig.  4D) .
The e(y)2 protein is associated with chromatin. Considering the above-mentioned properties of e(y)2 protein, one might expect e(y)2 to be associated with chromosomes (37, 17) . Antibody staining of Drosophila polytene chromosomes shows e(y)2 to be located in a large number of loci. Approximately 200 strong e(y)2-binding sites were detected on polytene chromosomes (Fig. 5A) . The e(y)2 protein does not contain any known DNA-binding domain, suggesting that it binds DNA through the interaction with other proteins or multiprotein complexes. VOL. 21, 2001 e(y)2 FUNCTIONALLY INTERACTS WITH TAF II 40 5227 To test whether e(y)2 can associate with chromatin, we compared its ability to bind chromatin or naked DNA. Chromatin was assembled by incubating DNA template containing the RNA polymerase II promoter of hsp26 minigene that was immobilized on paramagnetic beads for 6 h with a cytoplasmic chromatin assembly extract from 0-to 90-min preblastoderm embryos (32) . The chromatin template did not contain e(y)2 since it was not detected in cytoplasmic extract used for nucleosome assembly (Fig. 5C) . The purified immobilized chromatin was incubated for 30 min in nuclear in vitro transcription extract from 0-to 6-h embryos (34) and washed with 100 mM KCl. Following the incubation of the chromatin template with the nuclear extract, the e(y)2 protein was efficiently bound to chromatin (Fig. 5D) . Note that the e(y)2 protein or the e(y)2-containing protein complexes had only a very low affinity for the naked DNA after incubation in nuclear extract [ Fig. 5D , BϩDNA(NE) and B(NE) as a control]. Thus, the e(y)2 protein or e(y)2-containing protein complexes are able to bind to chromatin templates in vitro.
The influence of e(y)2 on transcription in vitro. To investigate the function of e(y)2 at the molecular level, we studied the influence of the recombinant Drosophila protein on the GAL4-VP16 activated transcription in a cell-free system using chromatin templates. Chromatin was assembled on supercoiled (17M)5␤2G template, containing five GAL4-binding sites upstream of the mouse retinoic acid receptor ␤2 core promoter linked to Ϫ9 to ϩ1516 chicken ␤-globin gene sequences (12) . The naked pG1 (35) template containing Ϫ109 to ϩ1516 ␤-globin gene sequences was used as an internal control of basal transcription. Micrococcal nuclease digestion of FIG. 4 . e(y)2 and TAF II 40 are stably associated within a high-molecular-mass complex. (A) The nuclear extract was immunoprecipitated with polyclonal antibodies (␣) raised against dTBP, e(y)2, dTAF II 24, or a rabbit preimmune serum (control). The input nuclear fraction (Input), supernatant of the immunoprecipitations (SN), and the protein A-Sepharose-bound proteins (IP), washed with 500 mM KCl containing IP buffer, were resolved by SDS-PAGE on a 10 or 15% (lower panel) polyacrylamide gel. Blots were probed with antibodies raised against dTAF II 230, dTAF II 110, hGCN5, dTBP, dTAF II 40 , and e(y)2, respectively. Note that the aliquots for the IP lanes (A, C, and D) are two to three times larger than those for the Input and SN lanes (approximately 1/6 and 1/15 of the material, respectively), except in the panel for TAF II 40 , where approximately equal aliquots were taken. (B) Western blot analysis of fractions from Superose-6 gel filtration column with the antibodies against e(y)2 and different components of TFIID. The column was calibrated with thyroglobulin (670K) and ferritin (440K) size standards (Pharmacia). Protein fractions eluted from the column were separated by SDS-PAGE on a 10 or 15% (lower panel) polyacrylamide gel. After transfer, the blots were probed with antibodies against dTAF II 230, dTAF II 110, dTBP, dTAF II (17M)5␤2G chromatin templates demonstrates that the total chromatin structure (ethidium bromide staining [data not shown]) and nucleosome repeat length within the proximal promoter (Ϫ40 to ϩ5) (Fig. 6B) were not affected by the presence of e(y)2. The e(y)2 protein had no effect on transcription in the absence of activator (Fig. 6A) or on a chromatin template lacking GAL4-binding sites (data not shown). However, we observed in the presence of GAL4-VP16 a moderate (four-to fivefold) but reproducible activation of transcription by e(y)2 protein on chromatin but not on naked cognate DNA templates. This result suggests that e(y)2 can potentiate transcriptional activation from chromatin templates.
DISCUSSION
By combining biochemical and classical genetic approaches, we have characterized a new ubiquitously expressed, evolutionary conserved transcription factor, e(y)2. The e(y)2 gene was identified in a genetic screen designed to identify factors facilitating communication between enhancers and promoters (15) . Genetic data have shown that it influences the expression of a wide range of genes, suggesting that the e(y)2 gene plays a important role in transcription (13) (14) (15) 26) .
The e(y)2 mRNA is present at all stages of development. Furthermore, e(y)2 protein is present in all tissues and is associated with numerous sites along the entire length of the salivary gland polytene chromosomes, as could be expected for a factor playing role in transcription of vast spectrum of genes. Interestingly, approximately three times more sites were detected on polytene chromosomes with the anti-e(y)2 antibodies than with antibodies raised against dTAF II 16 and dTAF II 24 (17) .
Homologues of the e(y)2 protein were detected in many higher eukaryotes from mammals to plants. The high degree of evolutionary conservation of the protein (100% conservation among mammals) suggests an important role for e(y)2 protein in cell metabolism. As was the case for Drosophila, the e(y)2 mRNA was detected in many different tissues and at different stages of development in humans, rats, and mice. Thus, e(y)2 homologues also appear to be ubiquitous proteins. Database searches did not reveal any known functional domains in e(y)2. While e(y)2 does not contain any sequence similarity to the proteins of HMG family, it does share several features, including small size and chromatin binding.
What is the function of e(y)2 protein? The genetic data obtained previously revealed the interaction between e(y)1/ TAF II 40 and e(y)2 genes. The e(y)2 1 and e(y)1 1 mutations have the same effect on white and yellow expression, and the combination of these mutations is lethal (14, 15) . Interestingly, the lethality induced by combination of the e(y)2 1 and e(y)1 1 mutations cannot be suppressed by the high level of synthesis of the TAF II 40 protein lacking its carboxy terminus. All other The ratio of added recombinant e(y)2 to endogenous e(y)2 was 10 in lanes 2, 4, 7, and 9 or 2 in lane 5. S1 nuclease analysis was performed after deproteinization (see Materials and Methods). (B) Analysis of the structure of chromatin reconstituted in the presence or absence of e(y)2 (5 nM) and GAL4-VP16 (1 nM). The template was digested with various concentrations of micrococcal nuclease in a final volume of 80 l, separated on a 1.5% gel, and Southern blotted using a 32 P-labeled probe corresponding to the region from positions Ϫ40 to ϩ5 of the ␤2G proximal promoter. Hybridization with the probes corresponding to a region 5Ј of the GAL4 binding sites gave a similar result (data not shown). Importantly, the genetic interaction data is confirmed by biochemical experiments, since e(y)2 and TAF II 40 were found to interact in several distinct immunoprecipitation experiments either from a crude nuclear extract or from more purified fractions. Using gel filtration followed by immunoprecipitation, we showed that e(y)2 and TAF II 40 proteins are associated and cofractionate as an entity with a large molecular mass (600 to 900 kDa). The e(y)2 and TAF II 40 interaction in such an entity is relatively stable, surviving 1 M KCl treatment. Considering the size of the e(y)2-TAF II 40-containing fractions (600 to 900 kDa), it is highly possible that e(y)2 and TAF II 40 are associated with other proteins. However, e(y)2 and TAF II 40 seem not to be associated with TFIID, since we could not coimmunoprecipitate with e(y)2 TBP and some TFIIDassociated TAF II s from the corresponding fraction after gel filtration. It should be pointed out that dTAF II s are components of not only TFIID but also the recently described Drosophila TAF II -HAT (histone-acetyltransferase) complex (17) . Thus, our experiments suggest that TAF II 40 is a component of an unknown complex of 600 to 900 kDa, which also contains e(y)2.
If the anti-e(y)2 immunoprecipitation experiments are carried out with nonfractionated extracts, some TFIID components (i.e., TBP, dTAF II 230, and dTAF II 110) coimmunoprecipitate with e(y)2. This is in contrast to the absence of significant overlapping of the complexes containing e(y)2 and those of TBP and the above-mentioned TAF II s upon gel filtration (Fig. 4B) . A possible explanation for this is that, while the complex containing e(y)2 and TAF II 40 is stable, the binding of e(y)2 to TFIID is loose and is destroyed during fractionation. If the filter shown in Fig. 4B is overexposed, the traces of e(y)2 are visible in many more fractions, some overlapping with TFIID (not shown). Thus, a continuous dissociation of the complex could occur during migration through the column. A putative loose association of e(y)2 with TFIID may explain why e(y)2 has not been noticed before and why the addition of recombinant e(y)2 enhances the activity of the extract containing endogenous e(y)2 (Fig. 6) .
We observed that, in vitro, transcriptional activation by GAL4-VP16 was potentiated by e(y)2 on chromatin but not on naked DNA templates. Interestingly, there is no e(y)2 homologue in yeast, where regulation of transcription by high-order chromatin structure has not been well established. Perhaps e(y)2 regulates transcription directly through the action of the detected complex containing e(y)2 and TAF II 40 or through a putative loose interaction of e(y)2 with TFIID. Alternatively, it is conceivable that the complex containing e(y)2 may play a role in chromatin remodeling (3, 6, 8) .
